APA (7th ed.) Citation

KC, H., PR, H., M, M., KB, C., S, S., MF, K., . . . BA, K. (2025). An engineered IgM antibody targeting CD20 has enhanced complement-dependent cytotoxicity compared with an IgG. Experimental hematology, 152, 105250. https://doi.org/10.1016/j.exphem.2025.105250

Chicago Style (17th ed.) Citation

KC, Hart, Hinton PR, Manlusoc M, Carlin KB, Schneider S, Kotturi MF, Baliga R, and Keyt BA. "An Engineered IgM Antibody Targeting CD20 Has Enhanced Complement-dependent Cytotoxicity Compared with an IgG." Experimental Hematology 152 (2025): 105250. https://doi.org/10.1016/j.exphem.2025.105250.

MLA (9th ed.) Citation

KC, Hart, et al. "An Engineered IgM Antibody Targeting CD20 Has Enhanced Complement-dependent Cytotoxicity Compared with an IgG." Experimental Hematology, vol. 152, 2025, p. 105250, https://doi.org/10.1016/j.exphem.2025.105250.